Treatment of a pediatric patient with MET-amplified signet ring cell adenocarcinoma of the stomach with crizotinib

Pediatr Blood Cancer. 2018 Jun;65(6):e26984. doi: 10.1002/pbc.26984. Epub 2018 Jan 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Carcinoma, Signet Ring Cell / drug therapy*
  • Carcinoma, Signet Ring Cell / genetics
  • Carcinoma, Signet Ring Cell / pathology
  • Crizotinib / therapeutic use*
  • Gene Amplification*
  • Humans
  • Male
  • Prognosis
  • Proto-Oncogene Proteins c-met / genetics*
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / pathology

Substances

  • Crizotinib
  • MET protein, human
  • Proto-Oncogene Proteins c-met